COGSTATE LTD — Board/Management Information 2008

Aug 31, 2008

==> picture [230 x 47] intentionally omitted <==

ASX Announcement

Monday 1 September 2008

CogState Appoints Company Secretary

CogState Ltd (ASX: CGS) is pleased to announce the appointment of Tony Panther as Company Secretary, replacing Ms. Lauren Delaney, who has taken twelve months leave.

In addition to his appointment as Company Secretary, Tony will act as Finance Manager at CogState Ltd.

Tony has over 20 years finance and company secretarial experience in a number of industries, including utilities, financial services and public accounting. He has qualifications in commerce and law and is a member of the Institute of Chartered Accountants in Australia and Chartered Secretaries Australia.

About CogState

CogState Ltd (ASX: CGS) specialises in the development and commercialisation of rapid, computerised tests of cognition (brain function). The tests are sold to pharmaceutical, biotechnology, nutraceutical and functional food companies to quantify the effect of drugs or other interventions on human subjects participating in clinical trials.

Since sales into the clinical trials market began in 2004, CogState has secured agreements with organisations including Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Abbott Laboratories, Centres for Disease Control (USA), ALZA Corporation (a member of the Johnson and Johnson group), Lundbeck and Organon USA. CogState is currently expanding its existing activities in the US and European clinical trial markets.

For additional information:

Brad O’Connor Chief Executive Officer CogState Ltd. Ph: (03) 9664 1305 Mob: 0411 888 347 or (US mob) +1 203 435 1244 boconnor@cogstate.com